Differential effects of doxorubicin treatment on cell cycle arrest and Skp2 expression in breast cancer cells
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology (medical),Pharmacology,Oncology
Reference31 articles.
1. Prognostic and predictive indicators in operable breast cancer;Morabito;Clin Breast Cancer,2003
2. The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancers;Tsihlias;Annu Rev Med,1999
3. Decreased levels of the cell-cycle inhibitor p27Kip1 inhibitor protein: prognostic implications in primary breast cancer;Catzavelos;Nat Med,1997
4. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone or in combination, correlate with survival of young breast patients;Porter;Nat Med,1997
5. The cell cycle inhibitor p27 is an independent marker in small (T1 a, b) invasive breast carcinomas;Tan;Cancer Res,1997
Cited by 66 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PEMF Potentiates Doxorubicin-induced Late G2Arrest in MDA-MB-231 Breast Cancer Cells;Anticancer Research;2024-06-26
2. Synchronized Chemotherapy/Photothermal Therapy/Sonodynamic Therapy of Human Triple-Negative and Estrogen Receptor-Positive Breast Cancer Cells Using a Doxorubicin–Gold Nanoclusters–Albumin Nanobioconjugate;Ultrasound in Medicine & Biology;2024-06
3. SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies;Frontiers in Oncology;2024-03-15
4. Anticancer Potential of Pyridoxine-Based Doxorubicin Derivatives: An In Vitro Study;Life;2024-02-20
5. Does insulin make breast cancer cells resistant to doxorubicin toxicity?;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-05-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3